Dose reduction of biological therapies for inflammatory rheumatic diseases: what do patients think?

Scand J Rheumatol. 2019 May;48(3):251-252. doi: 10.1080/03009742.2018.1533034. Epub 2018 Nov 16.

Authors

D Wallis¹, C Holmes¹, C Holroyd¹, K Sonpal², J Zarroug², J Adams³, C J Edwards^{1

2}

Affiliations

¹ a Rheumatology Department , University Hospital Southampton NHS Foundation Trust , Southampton , UK.
² b NIHR Southampton Clinical Research Facility , University Hospital Southampton , Southampton , UK.
³ c Centre for Innovation and Leadership in Health Sciences , University of Southampton , Southampton , UK.

PMID: 30444159
DOI: 10.1080/03009742.2018.1533034

No abstract available

Publication types

Letter

MeSH terms

Adult
Arthritis, Rheumatoid* / drug therapy
Arthritis, Rheumatoid* / psychology
Biological Therapy* / ethics
Biological Therapy* / methods
Decision Making / ethics
Female
Focus Groups
Humans
Male
Middle Aged
Off-Label Use
Patient Participation* / methods
Patient Participation* / psychology
Patient Preference / statistics & numerical data
Spondylitis, Ankylosing* / drug therapy
Spondylitis, Ankylosing* / psychology
Surveys and Questionnaires
United Kingdom